Terms: = Kidney tumors AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
10 results:
1. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
Li L; Li M; Zheng J; Li Z; Chen X
Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
[TBL] [Abstract] [Full Text] [Related]
2. Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database.
Kim JK; Jung G; Kwak C; Jeong CW; Kang SH; Hong SH; Kim YJ; Chung J; Hwang EC; Kwon TG; Byun SS
PLoS One; 2023; 18(3):e0283483. PubMed ID: 36996119
[TBL] [Abstract] [Full Text] [Related]
3. [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
Dun S; Zou LP; Zhang MN; Wang YY; He W; Chen HM; Hu LY; Chen XQ; Lu Q; Pang LY; Liu LY; Tang LN; Wang B
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):852-856. PubMed ID: 31665839
[No Abstract] [Full Text] [Related]
4. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Schöffski P; Wozniak A; Escudier B; Rutkowski P; Anthoney A; Bauer S; Sufliarsky J; van Herpen C; Lindner LH; Grünwald V; Zakotnik B; Lerut E; Debiec-Rychter M; Marréaud S; Lia M; Raveloarivahy T; Collette S; Albiges L
Eur J Cancer; 2017 Dec; 87():147-163. PubMed ID: 29149761
[TBL] [Abstract] [Full Text] [Related]
5. Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, Remer EM, Kaouk JH. J Urol. 2015 Oct;194(4):892-896. [Epub 2015 April 23]. doi: 10.1016/j.juro.2015.03.128.
Meng M
Urol Oncol; 2017 May; 35(5):311-312. PubMed ID: 28359745
[TBL] [Abstract] [Full Text] [Related]
6. [Surgical treatment of bone metastases from renal cell carcinoma].
Wang H; Zhou N; Xu X; Zhai J; Zhu X; Li G; Wang J; Liu N; He F; Wang H; Huang G; Man L
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):289-92. PubMed ID: 24731497
[TBL] [Abstract] [Full Text] [Related]
7. [Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].
Song DJ; Yue LF; Yang HY; Jia XY; Zhang JJ; Xu YL; Guo F; Wang JX
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1876-80. PubMed ID: 24124738
[TBL] [Abstract] [Full Text] [Related]
8. Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size?
Mucksavage P; Ramchandani P; Malkowicz SB; Guzzo TJ
Urology; 2012 Jan; 79(1):28-31. PubMed ID: 22202542
[TBL] [Abstract] [Full Text] [Related]
9. [Economic evaluation of targeted biologic therapy in metastatic renal cell carcinoma].
Ondrácková B; Demlová R; Komínek J
Klin Onkol; 2010; 23(6):439-45. PubMed ID: 21351422
[TBL] [Abstract] [Full Text] [Related]
10. An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.
Wood C; Srivastava P; Bukowski R; Lacombe L; Gorelov AI; Gorelov S; Mulders P; Zielinski H; Hoos A; Teofilovici F; Isakov L; Flanigan R; Figlin R; Gupta R; Escudier B;
Lancet; 2008 Jul; 372(9633):145-154. PubMed ID: 18602688
[TBL] [Abstract] [Full Text] [Related]
